問卷
此案目前為暫存狀態
編修至YYYY/MM/DD
不開放編輯功能
Find Division/Department
Taipei Veterans General Hospital
All Location
All Division/Department
篩選
Developmental Phase
Phase I
Phase I/II
Phase II
Phase II/III
Phase III
Phase IV
Others
Trial Status
Not yet recruiting
Active
Completed
Recruitment Status
Recruiting
Terminated
Stop recruiting
Suspended
Study ended
Trial scale
Multi-Regional Multi-Center
Taiwan Multiple Center
Taiwan Single Center
The expected start time interval of the test
Trial Applicant
Hospital/Foundation
Pharmaceutical/Biopharmaceutical company
Contract Research Organization
Important Roles
Asia Regional PI
Taiwan National PI
Chairman/Global PI
Steering Committee
Advisory board
None
Audit by Sponsors/CRO
Sponsors
CRO
Investigator-initiated trial(IIT)
Yes
Filters
下載
2016-03-01 - 2018-10-31
Condition/Disease
Active immunization against influenza A virus H5N1 subtype
Test Drug
GlaxoSmithKline (GSK) Biologicals’ Influenza A/Indonesia/05/2005 (H5N1) vaccine adjuvanted with AS03
Participate Sites8Sites
Terminated7Sites
Division of Pediatrics
2014-08-08 - 2016-12-31
Acute Coronary Syndrome
Losmapimod
Participate Sites6Sites
Terminated6Sites
2018-10-01 - 2019-04-15
Participate Sites1Sites
Terminated1Sites
2017-04-01 - 2023-10-31
Participate Sites2Sites
Not yet recruiting1Sites
Recruiting1Sites
2011-01-01 - 2017-12-31
Postoperative adjuvant therapy for hepatitis virus-related liver cancer
PI-88 or matching placebo
Participate Sites9Sites
Terminated9Sites
2017-12-01 - 2018-12-20
Adjuvant treatment of Post- Resection Hepatocellular Carcinoma
Muparfostat (PI-88)
Participate Sites10Sites
Terminated8Sites
Study ended1Sites
Division of Others-
2006-03-01 - 2010-12-31
Terminated10Sites
2008-05-01 - 2012-05-31
Participate Sites11Sites
Terminated11Sites
2006-03-01 - 2012-03-01
Participate Sites4Sites
Study ended4Sites
2008-02-01 - 2010-09-01
Terminated4Sites
全部
